Active substance
Ibutilide
- US FDA 5
- Health Canada 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CORVERT | 0.1MG/ML | injectable · injection | PFIZER | Prescription | 28 Dec 1995 |
| IBUTILIDE FUMARATE | 0.1MG/ML | injectable · injection | AVET LIFESCIENCES | Prescription | 1 Apr 2024 |
| IBUTILIDE FUMARATE | 0.1MG/ML | injectable · injection | LUITPOLD | Discontinued | 11 Jan 2010 |
| IBUTILIDE FUMARATE | 0.1MG/ML | injectable · injection | PHARMOBEDIENT | Discontinued | 11 Jan 2010 |
| IBUTILIDE FUMARATE | 0.1MG/ML | injectable · injection | MYLAN INSTITUTIONAL | Discontinued | 11 Jan 2010 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CORVERT | 02242470 | 0.1 MG / ML | SOLUTION · INTRAVENOUS | PFIZER CANADA ULC |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.